---
kind: "section"
citation: "21 C.F.R. § 520.370"
title: "21"
number: "520.370"
heading: "Cefpodoxime tablets."
url: "https://uscodex.org/cfr/21/520.370"
---

# §520.370. Cefpodoxime tablets.

- (a) **Specifications.**
  - (1) **Each tablet contains cefpodoxime proxetil equivalent to 100 or 200 milligrams (mg) cefpodoxime.**
  - (2) **Each chewable tablet contains cefpodoxime proxetil equivalent to 100 or 200 mg cefpodoxime.**
- (b) **Sponsors.** See sponsors in [§ 510.600(c)](/cfr/21/510.600.md?p=c) of this chapter for uses as follows:
  - (1) **Nos.** 017033 and 086101 for use of product in [paragraph (a)(1)](#a-1) of this section as in [paragraph (c)](#c) of this section.
  - (2) **No.** 054771 for use of products in [paragraph (a)](#a) of this section as in [paragraph (c)](#c) of this section.
- (c) **Conditions of use in dogs—**
  - (1) **Amount.** 5 to 10 mg per kilogram (2.3 to 4.5 mg per pound) body weight daily for 5 to 7 days, or for 2 to 3 days beyond the cessation of clinical signs, up to a maximum of 28 days.
  - (2) **Indications for use.** For the treatment of skin infections (wounds and abscesses) caused by susceptible strains of Staphylococcus pseudintermedius, S. aureus, Streptococcus canis (group G, beta-hemolytic), Escherichia coli, Pasteurella multocida, and Proteus mirabilis.
  - (3) **Limitations.** Federal law restricts this drug to use by or on the order of a licensed veterinarian.

## Notes

### Amendments

[69 FR 52815, Aug. 30, 2004, as amended at 78 FR 5714, Jan. 28, 2013; 79 FR 28819, May 20, 2014; 80 FR 13229, Mar. 13, 2015; 82 FR 12169, Mar. 1, 2017; 88 FR 16547, Mar. 20, 2023; 91 FR 5300, Feb. 6, 2026]

### Authority

Authority: 21 U.S.C. 360b.

### Source

Source: 40 FR 13838, Mar. 27, 1975, unless otherwise noted.

### Amendments

[69 FR 52815, Aug. 30, 2004, as amended at 78 FR 5714, Jan. 28, 2013; 79 FR 28819, May 20, 2014; 80 FR 13229, Mar. 13, 2015; 82 FR 12169, Mar. 1, 2017; 88 FR 16547, Mar. 20, 2023; 91 FR 5300, Feb. 6, 2026]